161 related articles for article (PubMed ID: 20158477)
41. The role of the linker between the SH2 domain and catalytic domain in the regulation and function of Src.
Gonfloni S; Williams JC; Hattula K; Weijland A; Wierenga RK; Superti-Furga G
EMBO J; 1997 Dec; 16(24):7261-71. PubMed ID: 9405355
[TBL] [Abstract][Full Text] [Related]
42. Simultaneous assay of Src SH3 and SH2 domain binding using different wavelength fluorescence polarization probes.
Lynch BA; Minor C; Loiacono KA; van Schravendijk MR; Ram MK; Sundaramoorthi R; Adams SE; Phillips T; Holt D; Rickles RJ; MacNeil IA
Anal Biochem; 1999 Nov; 275(1):62-73. PubMed ID: 10542110
[TBL] [Abstract][Full Text] [Related]
43. SH3 domain of c-Src governs its dynamics at focal adhesions and the cell membrane.
Machiyama H; Yamaguchi T; Sawada Y; Watanabe TM; Fujita H
FEBS J; 2015 Oct; 282(20):4034-55. PubMed ID: 26258764
[TBL] [Abstract][Full Text] [Related]
44. The Two Isoforms of Lyn Display Different Intramolecular Fuzzy Complexes with the SH3 Domain.
Teixeira JMC; Fuentes H; Bielskutė S; Gairi M; Żerko S; Koźmiński W; Pons M
Molecules; 2018 Oct; 23(11):. PubMed ID: 30360468
[TBL] [Abstract][Full Text] [Related]
45. A non-catalytic function of the Src family tyrosine kinases controls prolactin-induced Jak2 signaling.
García-Martínez JM; Calcabrini A; González L; Martín-Forero E; Agulló-Ortuño MT; Simon V; Watkin H; Anderson SM; Roche S; Martín-Pérez J
Cell Signal; 2010 Mar; 22(3):415-26. PubMed ID: 19892015
[TBL] [Abstract][Full Text] [Related]
46. Artemin activates axonal growth via SFK and ERK-dependent signalling pathways in mature dorsal root ganglia neurons.
Jeong DG; Park WK; Park S
Cell Biochem Funct; 2008; 26(2):210-20. PubMed ID: 17868192
[TBL] [Abstract][Full Text] [Related]
47. Targeting Self-Binding Peptides as a Novel Strategy To Regulate Protein Activity and Function: A Case Study on the Proto-oncogene Tyrosine Protein Kinase c-Src.
Bai Z; Hou S; Zhang S; Li Z; Zhou P
J Chem Inf Model; 2017 Apr; 57(4):835-845. PubMed ID: 28345935
[TBL] [Abstract][Full Text] [Related]
48. Structure and dynamic regulation of Src-family kinases.
Engen JR; Wales TE; Hochrein JM; Meyn MA; Banu Ozkan S; Bahar I; Smithgall TE
Cell Mol Life Sci; 2008 Oct; 65(19):3058-73. PubMed ID: 18563293
[TBL] [Abstract][Full Text] [Related]
49. Interaction between the SH3 domain of Src family kinases and the proline-rich motif of HTLV-1 p13: a novel mechanism underlying delivery of Src family kinases to mitochondria.
Tibaldi E; Venerando A; Zonta F; Bidoia C; Magrin E; Marin O; Toninello A; Bordin L; Martini V; Pagano MA; Brunati AM
Biochem J; 2011 Nov; 439(3):505-16. PubMed ID: 21732913
[TBL] [Abstract][Full Text] [Related]
50. C-terminal Src kinase (CSK) and CSK-homologous kinase (CHK)--endogenous negative regulators of Src-family protein kinases.
Chong YP; Mulhern TD; Cheng HC
Growth Factors; 2005 Sep; 23(3):233-44. PubMed ID: 16243715
[TBL] [Abstract][Full Text] [Related]
51. Regulation of mRNA splicing and transport by the tyrosine kinase activity of src.
Gondran P; Dautry F
Oncogene; 1999 Apr; 18(16):2547-55. PubMed ID: 10353598
[TBL] [Abstract][Full Text] [Related]
52. Dynamic coupling between the SH2 and SH3 domains of c-Src and Hck underlies their inactivation by C-terminal tyrosine phosphorylation.
Young MA; Gonfloni S; Superti-Furga G; Roux B; Kuriyan J
Cell; 2001 Apr; 105(1):115-26. PubMed ID: 11301007
[TBL] [Abstract][Full Text] [Related]
53. SH2 domain-mediated activation of an SRC family kinase is not required to initiate Ca2+ release at fertilization in mouse eggs.
Mehlmann LM; Jaffe LA
Reproduction; 2005 May; 129(5):557-64. PubMed ID: 15855619
[TBL] [Abstract][Full Text] [Related]
54. The SH3 domain of Src tyrosyl protein kinase interacts with the N-terminal splice region of the PDE4A cAMP-specific phosphodiesterase RPDE-6 (RNPDE4A5).
O'Connell JC; McCallum JF; McPhee I; Wakefield J; Houslay ES; Wishart W; Bolger G; Frame M; Houslay MD
Biochem J; 1996 Aug; 318 ( Pt 1)(Pt 1):255-61. PubMed ID: 8761480
[TBL] [Abstract][Full Text] [Related]
55. The Activation of c-Src Tyrosine Kinase: Conformational Transition Pathway and Free Energy Landscape.
Fajer M; Meng Y; Roux B
J Phys Chem B; 2017 Apr; 121(15):3352-3363. PubMed ID: 27715044
[TBL] [Abstract][Full Text] [Related]
56. Novel autophosphorylation sites of Src family kinases regulate kinase activity and SH2 domain-binding capacity.
Weir ME; Mann JE; Corwin T; Fulton ZW; Hao JM; Maniscalco JF; Kenney MC; Roman Roque KM; Chapdelaine EF; Stelzl U; Deming PB; Ballif BA; Hinkle KL
FEBS Lett; 2016 Apr; 590(8):1042-52. PubMed ID: 27001024
[TBL] [Abstract][Full Text] [Related]
57. Linker length dependent binding of a focal adhesion kinase derived peptide to the Src SH3-SH2 domains.
Lindfors HE; Venkata BS; Drijfhout JW; Ubbink M
FEBS Lett; 2011 Feb; 585(4):601-5. PubMed ID: 21266176
[TBL] [Abstract][Full Text] [Related]
58. Src family kinases as mediators of endothelial permeability: effects on inflammation and metastasis.
Kim MP; Park SI; Kopetz S; Gallick GE
Cell Tissue Res; 2009 Jan; 335(1):249-59. PubMed ID: 18815812
[TBL] [Abstract][Full Text] [Related]
59. UCS15A, a novel small molecule, SH3 domain-mediated protein-protein interaction blocking drug.
Oneyama C; Nakano H; Sharma SV
Oncogene; 2002 Mar; 21(13):2037-50. PubMed ID: 11960376
[TBL] [Abstract][Full Text] [Related]
60. SH2 domain-mediated interaction of inhibitory protein tyrosine kinase Csk with protein tyrosine phosphatase-HSCF.
Wang B; Lemay S; Tsai S; Veillette A
Mol Cell Biol; 2001 Feb; 21(4):1077-88. PubMed ID: 11158295
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
